We are live on ! Find out more
CVM.WS

Cel-Sci Corp Series S

Delisted

CVM.WS was delisted on the 8th of October, 2018.

6 hedge funds and large institutions have $66K invested in Cel-Sci Corp Series S in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less funds holding

Funds holding: 76 (-1)

33% less capital invested

Capital invested by funds: $98K → $66K (-$32K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PWAM
1
Park West Asset Management
California
$35K
TCM
2
Tenor Capital Management
New York
$19K
Millennium Management
3
Millennium Management
New York
$10K
Bank of America
4
Bank of America
North Carolina
$1K +$608 +33,609 New
Ameriprise
5
Ameriprise
Minnesota
$1K +$1.09K +60,000 New
VF
6
Virtu Financial
New York
-$2K -78,651 Closed
UBS Group
7
UBS Group
Switzerland
-$2K -68,433 Closed
TSS
8
Two Sigma Securities
New York
-$1K -29,547 Closed

CVM.WS Hedge Fund Activity: Q4 2017 in Review

6 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cel-Sci Corp Series S (CVM.WS) for Q4 2017, worth a combined $66K — down 33% from $98K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CVM.WS and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Ameriprise, opening a new position worth an estimated $1.09K. The largest seller was UBS Group, exiting entirely with an estimated $2K sold.

  • 6 institutional investors held Cel-Sci Corp Series S (CVM.WS) as of Q4 2017, down from 7 in Q3 2017.
  • Funds reported $66K of Cel-Sci Corp Series S stock for Q4 2017, down 33% quarter-over-quarter.
  • 2 funds opened new Cel-Sci Corp Series S positions in Q4 2017 and 3 closed out, a net change of -1 holder.
  • The largest Cel-Sci Corp Series S buyer in Q4 2017 was Ameriprise, an estimated $1.09K added.
  • The largest Cel-Sci Corp Series S seller in Q4 2017 was UBS Group, an estimated $2K sold.

Based on aggregated 13F filings for Q4 2017.